Indefinite Delivery Contract 36C24E25D0038

Award Date 9/22/25
Last Date to Order 9/21/29
Contracting Federal Agency
Veterans Integrated Service Network 4
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a $37.5 million Indefinite Delivery Contract (IDC) granted by the National Heart, Lung, and Blood Institute (NHLBI) to The Leland Stanford Junior University (Stanford University), a private research institution. The IDC, which runs through September 2033, tasks Stanford with providing data analysis, integration, and management services to support the NHLBI's Trans-Omics for Precision Medicine initiative. This includes work related to genomics, epigenomics,...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with the Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22), a civilian agency. The prime contractor is CD Biosciences Inc., a small business research product supplier and contract research organization. The IDC, valued at $178,000, is for specialized TCR sequencing services to support a stroke study. The contract covers comprehensive genomic sequencing, bioinformatics analysis, and...
The federal contract IDV award is for the provision of Genomics Core Services to the U.S. Department of Veterans Affairs (VA). The prime contractor is The Regents of the University of California, San Francisco (UCSF), a leading academic medical center and research institution. The contract has a ceiling value of $233,964.24 and a period of performance through August 31, 2026. It is a single-award Indefinite Delivery Contract, with no set-asides used. The funding agency is the VA's Veterans...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Genomind Inc. The contract, valued at up to $225,000.00, is for 621 II, MEDICAL LABORATORY TESTING & ANALYSIS SERVICES and has a period of performance through May 31, 2030. As an FSS contract, this is a multiple award vehicle that allows the VA and other federal agencies to procure these medical laboratory testing and analysis services. The contract does not...
The federal contract IDV award is a single-award indefinite delivery contract (IDC) issued by the Department of Veterans Affairs (VA) to Brigham & Women's Hospital Inc., a non-profit academic medical center and research institution affiliated with Harvard Medical School. The $1.604 million contract, which has a period of performance through December 31, 2025, aims to procure "EFFECTIVENESS RESEARCH WITH REAL WORLD DATA TO SUPPORT FDA'S REGULATORY DECISION MAKING: A REAL WORLD EVIDENCE...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Infinity Biologix LLC, doing business as Sampled Division, for genomic analysis services worth up to $86.5 million over the period of performance ending September 29, 2025. This single-award IDC was issued by the VA Headquarters and does not include any socioeconomic set-asides. Under this IDC, the VA has issued multiple firm-fixed-price delivery orders to Infinity Biologix for genomic sequencing, DNA...
The federal contract IDV award is for single cell sequencing services provided by the University of Washington to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The single-award, indefinite delivery contract has a ceiling value of $846,644.64 and a period of performance from August 15, 2024 to August 14, 2029. No set-aside was used for this contract. The University of Washington, as the prime contractor, will provide DNA methylation...
This federal contract Indefinite Delivery Vehicle (IDV) is a single-award contract awarded to Transnetyx, Inc., a for-profit organization specializing in advanced genetic testing and analysis services. The $375,000 IDV was awarded by the Department of Veterans Affairs (VA) for automated genotyping services to support animal research at the San Francisco VA Healthcare System. The contract includes a 12-month base period from June 24, 2025, to June 23, 2026, with four one-year option periods. Task...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Fred Hutchinson Cancer Research Center, a non-profit organization, to provide core support services and DNA extraction in support of VHA programs operated through Veterans Integrated Service Network 20 (VISN 20). The IDC, valued at up to $337,347 over a two-year period through September 2024, has a single award structure without any set-aside designations. Two...
The federal contract IDV is an Indefinite Delivery Contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Xcell Science Incorporated, a woman-owned small business. The contract has a ceiling value of $3,609,000.00 and is a delivery order under the "Gene Insertion - Pluripotent Stem Cells 2012-2017" IDIQ contract. The contract is for SUPPORT- PROFESSIONAL: OTHER services, with a current task order valued at $1,001,068.00 and a completion date of...

The federal contract IDV award is a single-award Indefinite Delivery Contract awarded to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, a non-profit research organization. The contract has a ceiling value of $500,000 and an ultimate completion date of September 21, 2029, with an award date of September 22, 2025.

The contract is funded by the Department of Veterans Affairs (VA) and supports specialized DNA and medical study services focused on genetic factors influencing blood pressure and arterial stiffness. The work involves developing standard procedures, receiving and tracking DNA samples, performing isolation and genotyping, conducting genetic analysis, and providing general scientific consultation and oversight. The requirement encompasses approximately 250 DNA samples to be processed over four years across three VA study sites in Madison, WI, Nashville, TN, and Alabama. The primary objective is to investigate the potential of a blood pressure polygenic risk score in predicting individual responses to blood pressure targets, specifically regarding load-dependent arterial stiffness.

Generated 9/23/25, 9:46 AM